Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Langetermijneffectiviteit van Ad26.RSV.preF-RSV preF-eiwitvaccin
dec 2024 | Vaccinatie, Virale infecties